Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 3,000 shares at $52.29 ($156K) on 2018-02-28, disclosed to the SEC on 2018-03-01.
Open-market sale of $156k IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.02 | 900 | $46K | 29.5% |
| 2 | $52.29 | 2,100 | $110K | 70.5% |
| Total | $51.91 avg | 3,000 | $156K | 100% |
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |